• Julie Ottoy
  • Jeroen Verhaeghe
  • Ellis Niemantsverdriet
  • Ellen De Roeck
  • Leonie Wyffels
  • Sarah Ceyssens
  • Christine Van Broeckhoven
  • Sebastiaan Engelborghs
  • Sigrid Stroobants
  • Steven Staelens

INTRODUCTION: Dual-biomarker positron emission tomography (PET), providing complementary information on cerebral blood flow and amyloid-β deposition, is of clinical interest for Alzheimer's disease (AD). The purpose of this study was to validate the perfusion components of early-phase 18F-florbetapir (eAV45), the 18F-AV45 delivery rate (R1), and 18F-FDG against 15O-H2O PET and assess how they change with disease severity.

METHODS: This study included ten controls, 19 amnestic mild cognitive impairment, and 10 AD dementia subjects. Within-subject regional correlations between modalities, between-group regional and voxel-wise analyses of covariance per modality, and receiver operating characteristic analyses for discrimination between groups were performed.

RESULTS: FDG standardized uptake value ratio, eAV45 (0-2 min) standardized uptake value ratio, and AV45-R1 were significantly associated with H2O PET (regional Pearson r = 0.54-0.82, 0.70-0.94, and 0.65-0.92, respectively; P < .001). All modalities confirmed reduced cerebral blood flow in the posterior cingulate of patients with amnestic mild cognitive impairment and AD dementia, which was associated with lower cognition (r = 0.36-0.65, P < .025) and could discriminate between patient and control groups (area under the curve > 0.80). However, eAV45 was less sensitive to reflect the disease severity than AV45-R1 or FDG.

DISCUSSION: R1 is preferable over eAV45 for accurate representation of brain perfusion in dual-biomarker PET for AD.

Original languageEnglish
Pages (from-to)1172-1182
Number of pages11
JournalAlzheimer's & Dementia
Issue number9
Early online date9 Aug 2019
Publication statusPublished - 1 Sep 2019

    Research areas

  • (15)O-H(2)O, (18)F-AV45, (18)F-FDG, Alzheimer's disease, Cerebral blood flow;, Dual-phase PET, Early-phase PET, Perfusion imaging, R1

ID: 46743083